Quantitative Analyses of Urinary Pyridinoline and Deoxypyridinoline Excretion in Patients with Hyperthyroidism
Overview
Affiliations
It is well established that bone turnover increases and bone resorption exceeds bone formation in patients with hyperthyroidism. Recently, urinary pyridinoline and deoxypyridinoline have been employed as indicators of bone resorption. In this study, urinary pyridinoline and deoxypyridinoline levels in fourteen female patients with untreated hyperthyroidism were measured and compared with levels in 134 healthy females. Values of urinary pyridinoline and deoxypyridinoline were significantly higher than in age-matched controls. Moreover, values of serum free triiodothyronine correlated with urinary pyridinoline (r = 0.769, p < 0.01), and urinary deoxypyridinoline (r = 0.799, p < 0.001) in patients with hyperthyroidism.
Migliorini F, Maffulli N, Spiezia F, Peretti G, Tingart M, Giorgino R J Orthop Surg Res. 2021; 16(1):351.
PMID: 34059108 PMC: 8165809. DOI: 10.1186/s13018-021-02497-0.
Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms.
Hu H, Rabinowitz M, Smith D Environ Health Perspect. 1998; 106(1):1-8.
PMID: 9417769 PMC: 1532948. DOI: 10.1289/ehp.981061.
Kawana K, Takahashi M, Kushida K, Hoshino H, Sakata S, Inoue T J Endocrinol Invest. 1996; 19(8):499-504.
PMID: 8905471 DOI: 10.1007/BF03349007.
Rosen H, Dresner-Pollak R, Moses A, Rosenblatt M, Zeind A, Clemens J Calcif Tissue Int. 1994; 54(1):26-9.
PMID: 8118749 DOI: 10.1007/BF00316285.
Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis.
Sano M, Kushida K, Takahashi M, Ohishi T, Kawana K, Okada M Br J Cancer. 1994; 70(4):701-3.
PMID: 7917922 PMC: 2033391. DOI: 10.1038/bjc.1994.377.